H-ALKDVEERV-OH

Ref. 3D-PP48260

Informations sur le produit

• Nom: H-ALKDVEERV-OH

Description

Peptide H-ALKDVEERV-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-ALKDVEERV-OH include the following: Two new tumor-specific antigenic peptides encoded by gene MAGE-C2 and presented to cytolytic T lymphocytes by HLA-A2 W Ma, C Germeau, N Vigneron - journal of cancer, 2004 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.20038 Antigen spreading contributes to MAGE vaccination-induced regression of melanoma metastases V Corbiere , J Chapiro, V Stroobant, W Ma, C Lurquin - Cancer research, 2011 - AACRhttps://aacrjournals.org/cancerres/article-abstract/71/4/1253/571730 Analysis of the Processing of Seven Human TA by Intermediate - 2012 - researchgate.nethttps://www.researchgate.net/profile/Nicolas-Parmentier/publication/230747744_Analysis_of_the_Processing_of_Seven_Human_Tumor_Antigens_by_Intermediate_Proteasomes/links/56f1353708aec9e096b31545/Analysis-of-the-Processing-of-Seven-Human-Tumor-Antigens-by-Intermediate-Proteasomes.pdf TCR gene transfer: MAGE-C2/HLA-A2 and MAGE-A3/HLA-DP4 epitopes as melanoma-specific immune targets T Straetemans, M Van Brakel - Journal of , 2012 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1155/2012/586314 Clinical Correlation of Function and TCR vbeta Diversity of MAGE-C2-Specific CD8+ T Cell Response in Esophageal Cancer P Li, X Chen, Y Ping, G Qin, L Huang - The Journal of , 2022 - journals.aai.orghttps://journals.aai.org/jimmunol/article/209/6/1039/234192 Immunoproteasome down-modulation enhances the ability of dendritic cells to stimulate antitumor immunity J Dannull, DT Lesher, R Holzknecht - Blood, The Journal , 2007 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/110/13/4341/103257 Destructive cleavage of antigenic peptides either by the immunoproteasome or by the standard proteasome results in differential antigen presentation J Chapiro, S Claverol, F Piette, W Ma - The Journal of , 2006 - journals.aai.orghttps://journals.aai.org/jimmunol/article/176/2/1053/73604 High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens C Germeau, W Ma, F Schiavetti, C Lurquin - The Journal of , 2005 - rupress.orghttps://rupress.org/jem/article-abstract/201/2/241/54831 Plasmacytoid dendritic cells and cancer immunotherapy C Fu, L Zhou, QS Mi , A Jiang - Cells, 2022 - mdpi.comhttps://www.mdpi.com/2073-4409/11/2/222 Analysis of the processing of seven human tumor antigens by intermediate proteasomes B Guillaume, V Stroobant - The Journal of , 2012 - journals.aai.orghttps://journals.aai.org/jimmunol/article/189/7/3538/86340

• Marque: Biosynth